• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明确 KDM2B 相关神经发育障碍及其相关 DNA 甲基化特征。

Delineation of a KDM2B-related neurodevelopmental disorder and its associated DNA methylation signature.

机构信息

Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.

出版信息

Genet Med. 2023 Jan;25(1):49-62. doi: 10.1016/j.gim.2022.09.006. Epub 2022 Nov 1.

DOI:10.1016/j.gim.2022.09.006
PMID:36322151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9825659/
Abstract

PURPOSE

Pathogenic variants in genes involved in the epigenetic machinery are an emerging cause of neurodevelopment disorders (NDDs). Lysine-demethylase 2B (KDM2B) encodes an epigenetic regulator and mouse models suggest an important role during development. We set out to determine whether KDM2B variants are associated with NDD.

METHODS

Through international collaborations, we collected data on individuals with heterozygous KDM2B variants. We applied methylation arrays on peripheral blood DNA samples to determine a KDM2B associated epigenetic signature.

RESULTS

We recruited a total of 27 individuals with heterozygous variants in KDM2B. We present evidence, including a shared epigenetic signature, to support a pathogenic classification of 15 KDM2B variants and identify the CxxC domain as a mutational hotspot. Both loss-of-function and CxxC-domain missense variants present with a specific subepisignature. Moreover, the KDM2B episignature was identified in the context of a dual molecular diagnosis in multiple individuals. Our efforts resulted in a cohort of 21 individuals with heterozygous (likely) pathogenic variants. Individuals in this cohort present with developmental delay and/or intellectual disability; autism; attention deficit disorder/attention deficit hyperactivity disorder; congenital organ anomalies mainly of the heart, eyes, and urogenital system; and subtle facial dysmorphism.

CONCLUSION

Pathogenic heterozygous variants in KDM2B are associated with NDD and a specific epigenetic signature detectable in peripheral blood.

摘要

目的

涉及表观遗传机制的基因中的致病变异是神经发育障碍(NDD)的一个新兴病因。赖氨酸去甲基酶 2B(KDM2B)编码一种表观遗传调节剂,小鼠模型表明其在发育过程中具有重要作用。我们着手确定 KDM2B 变体是否与 NDD 相关。

方法

通过国际合作,我们收集了携带杂合 KDM2B 变体个体的数据。我们应用外周血 DNA 样本的甲基化阵列来确定与 KDM2B 相关的表观遗传特征。

结果

我们共招募了 27 名携带 KDM2B 杂合变异的个体。我们提供了证据,包括共享的表观遗传特征,支持 15 种 KDM2B 变体的致病性分类,并确定 CxxC 结构域为突变热点。失活功能和 CxxC 结构域错义变体均呈现特定的亚表型特征。此外,在多个个体的双重分子诊断中鉴定出了 KDM2B 表型特征。我们的努力产生了 21 名携带杂合(可能)致病性变异的个体队列。该队列中的个体表现为发育迟缓和/或智力障碍;自闭症;注意力缺陷障碍/注意缺陷多动障碍;先天性器官异常主要涉及心脏、眼睛和泌尿生殖系统;以及细微的面部畸形。

结论

KDM2B 中的致病性杂合变体与 NDD 相关,并在外周血中可检测到特定的表观遗传特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/610d20e41e7f/nihms-1860492-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/053dc8542ea0/nihms-1860492-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/4746e1fd9aac/nihms-1860492-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/ac1c44a379ab/nihms-1860492-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/610d20e41e7f/nihms-1860492-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/053dc8542ea0/nihms-1860492-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/4746e1fd9aac/nihms-1860492-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/ac1c44a379ab/nihms-1860492-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e12/9825659/610d20e41e7f/nihms-1860492-f0004.jpg

相似文献

1
Delineation of a KDM2B-related neurodevelopmental disorder and its associated DNA methylation signature.明确 KDM2B 相关神经发育障碍及其相关 DNA 甲基化特征。
Genet Med. 2023 Jan;25(1):49-62. doi: 10.1016/j.gim.2022.09.006. Epub 2022 Nov 1.
2
MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature.MSL2 变异导致一种神经发育综合征,表现为协调障碍、癫痫、特定的畸形和独特的外显子特征。
Am J Hum Genet. 2024 Jul 11;111(7):1330-1351. doi: 10.1016/j.ajhg.2024.05.001. Epub 2024 May 29.
3
Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature.截断 Floating-Harbor 综合征位点以外的 SRCAP 变异会导致具有特定 DNA 甲基化特征的明显神经发育障碍。
Am J Hum Genet. 2021 Jun 3;108(6):1053-1068. doi: 10.1016/j.ajhg.2021.04.008. Epub 2021 Apr 27.
4
DNA methylation episignature in Gabriele-de Vries syndrome.Gabriele-de Vries 综合征中的 DNA 甲基化表观遗传标志。
Genet Med. 2022 Apr;24(4):905-914. doi: 10.1016/j.gim.2021.12.003. Epub 2022 Jan 10.
5
Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.使用 EpigenCentral 生成 DNA 甲基化特征并对罕见神经发育障碍中的变体进行分类。
Curr Protoc. 2022 Nov;2(11):e597. doi: 10.1002/cpz1.597.
6
SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability.SRSF1 杂合性不足是导致与智力障碍相关的综合征性发育障碍的原因。
Am J Hum Genet. 2023 May 4;110(5):790-808. doi: 10.1016/j.ajhg.2023.03.016. Epub 2023 Apr 17.
7
An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.一个 HNRNPK 特异性 DNA 甲基化特征解释了错义变异,并扩展了 Au-Kline 综合征的表型谱。
Am J Hum Genet. 2022 Oct 6;109(10):1867-1884. doi: 10.1016/j.ajhg.2022.08.014. Epub 2022 Sep 20.
8
Functional Insight into and Refinement of the Genomic Boundaries of the -Neurodevelopmental Disorder Episignature.深入了解和完善 -Neurodevelopmental 障碍 Episignature 的基因组边界
Int J Mol Sci. 2023 Sep 18;24(18):14240. doi: 10.3390/ijms241814240.
9
Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders.全基因组表观遗传特征有助于 PURA 基因变异的分类,并揭示了 PURA 相关神经发育障碍的发病机制。
Genet Med. 2024 Aug;26(8):101167. doi: 10.1016/j.gim.2024.101167. Epub 2024 May 17.
10
Positional cloning and comprehensive mutation analysis identified a novel KDM2B mutation in a Japanese family with minor malformations, intellectual disability, and schizophrenia.定位克隆和全面突变分析在一个有轻微畸形、智力障碍和精神分裂症的日本家族中发现了一个新的 KDM2B 突变。
J Hum Genet. 2021 Jun;66(6):597-606. doi: 10.1038/s10038-020-00889-4. Epub 2021 Jan 6.

引用本文的文献

1
KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome.CXXC结构域中的KDM2B变体损害其DNA结合能力,并导致一种独特的神经发育综合征。
Hum Mol Genet. 2025 Aug 16;34(16):1353-1367. doi: 10.1093/hmg/ddaf082.
2
Maternal asthma and newborn DNA methylation.母亲哮喘与新生儿DNA甲基化
Clin Epigenetics. 2025 May 10;17(1):79. doi: 10.1186/s13148-025-01858-4.
3
De novo variants in cause a syndromic neurodevelopmental disorder.[具体基因名称]中的新生变异会导致一种综合征性神经发育障碍。 (你提供的原文中“De novo variants in ”后面缺少具体的基因名称等关键信息,所以这里只能给出一个大致翻译示例,需补充完整信息才能准确翻译。)

本文引用的文献

1
Impaired KDM2B-mediated PRC1 recruitment to chromatin causes defective neural stem cell self-renewal and ASD/ID-like behaviors.KDM2B介导的PRC1与染色质的募集受损会导致神经干细胞自我更新缺陷以及类似自闭症谱系障碍/智力障碍的行为。
iScience. 2022 Jan 7;25(2):103742. doi: 10.1016/j.isci.2022.103742. eCollection 2022 Feb 18.
2
Childhood-onset dystonia-causing KMT2B variants result in a distinctive genomic hypermethylation profile.导致儿童期起病的肌张力障碍的 KMT2B 变异导致独特的基因组高甲基化谱。
Clin Epigenetics. 2021 Aug 11;13(1):157. doi: 10.1186/s13148-021-01145-y.
3
Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders.
medRxiv. 2025 Apr 1:2025.03.31.25324695. doi: 10.1101/2025.03.31.25324695.
4
FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature.FBXO22基因缺陷定义了一种与独特表观遗传特征相关的生长受限和多系统异常的多效性综合征。
Am J Hum Genet. 2025 May 1;112(5):1233-1246. doi: 10.1016/j.ajhg.2025.03.013. Epub 2025 Apr 10.
5
Hao-Fountain syndrome protein USP7 controls neuronal differentiation via BCOR-ncPRC1.1.郝-方丹综合征蛋白USP7通过BCOR-ncPRC1.1控制神经元分化。
Genes Dev. 2025 Mar 3;39(5-6):401-422. doi: 10.1101/gad.352272.124.
6
Discovery of a DNA methylation profile in individuals with Sifrim-Hitz-Weiss syndrome.西夫里姆 - 希茨 - 魏斯综合征患者DNA甲基化谱的发现。
Am J Hum Genet. 2025 Feb 6;112(2):414-427. doi: 10.1016/j.ajhg.2024.12.020. Epub 2025 Jan 16.
7
Clinical evaluation of long-read sequencing-based episignature detection in developmental disorders.基于长读长测序的发育障碍表观特征检测的临床评估
Genome Med. 2025 Jan 10;17(1):1. doi: 10.1186/s13073-024-01419-z.
8
KDM2B regulates stroke injury by modulating OGT-mediated 0-GlcNAcylation of SLC7A11.KDM2B 通过调节 OGT 介导的 SLC7A11 的 0-GlcNAc 化来调节中风损伤。
Commun Biol. 2024 Nov 18;7(1):1530. doi: 10.1038/s42003-024-07251-w.
9
KDM2B and its peptides promote the stem cells from apical papilla mediated nerve injury repair in rats by intervening EZH2 function.KDM2B及其肽段通过干预EZH2功能促进大鼠根尖乳头干细胞介导的神经损伤修复。
Cell Prolif. 2025 Feb;58(2):e13756. doi: 10.1111/cpr.13756. Epub 2024 Oct 2.
10
Deciphering DNA Methylation in Gestational Diabetes Mellitus: Epigenetic Regulation and Potential Clinical Applications.解读妊娠期糖尿病中的 DNA 甲基化:表观遗传调控与潜在的临床应用。
Int J Mol Sci. 2024 Aug 29;25(17):9361. doi: 10.3390/ijms25179361.
临床表观基因组学:孟德尔疾病诊断的全基因组 DNA 甲基化分析。
Genet Med. 2021 Jun;23(6):1065-1074. doi: 10.1038/s41436-020-01096-4. Epub 2021 Feb 5.
4
Positional cloning and comprehensive mutation analysis identified a novel KDM2B mutation in a Japanese family with minor malformations, intellectual disability, and schizophrenia.定位克隆和全面突变分析在一个有轻微畸形、智力障碍和精神分裂症的日本家族中发现了一个新的 KDM2B 突变。
J Hum Genet. 2021 Jun;66(6):597-606. doi: 10.1038/s10038-020-00889-4. Epub 2021 Jan 6.
5
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
6
Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells.在原代小鼠细胞中与复制性衰老旁路相关的赖氨酸特异性去甲基化酶2B CxxC结构域的结构元件鉴定。
Protein J. 2020 Jun;39(3):232-239. doi: 10.1007/s10930-020-09895-z.
7
Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.评估 42 种孟德尔神经发育障碍疾病中的 DNA 甲基化表观遗传标记用于诊断和表型相关性。
Am J Hum Genet. 2020 Mar 5;106(3):356-370. doi: 10.1016/j.ajhg.2020.01.019. Epub 2020 Feb 27.
8
A genome-wide DNA methylation signature for SETD1B-related syndrome.一个与 SETD1B 相关的综合征的全基因组 DNA 甲基化特征。
Clin Epigenetics. 2019 Nov 4;11(1):156. doi: 10.1186/s13148-019-0749-3.
9
Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects.表观遗传机制的孟德尔疾病:出生后的可塑和治疗前景。
Hum Mol Genet. 2019 Nov 21;28(R2):R254-R264. doi: 10.1093/hmg/ddz174.
10
MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains.MetaDome:通过同源人蛋白结构域的聚集分析遗传变异的致病性。
Hum Mutat. 2019 Aug;40(8):1030-1038. doi: 10.1002/humu.23798. Epub 2019 Jun 18.